MedPath

investigator initiated study of long-term treatment of Rhododenol-induced Leukoderma with Bimaprost

Not Applicable
Conditions
Rhododenol-induced Leukoderma
Registration Number
JPRN-UMIN000030316
Lead Sponsor
Teikyo University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1) Age under twenty years old at the time of inforomed consent. 2) Those who were suspected of concomitant vitiligo vulgaris. 3) Those who show skin problems such as erythema at the site of target region. 4) Those subjects who were considered by the principal investigator or sub-investigator to be showing skin problem which might be related to previous study. 5) Those subjects who were considered by the principal investigator or sub-investigator to be difficult to comply with compliance. 6) Those who show allagic reaction against Bimatoprost. 7) Those women who are pregnant or possibly pregnant or during lactation or those who cannot agree with contraception during the study. 8) Those otherwise principal physician considered unsuitable to include in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of pigmentation after twelve months application of Bimatoprost on target region.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath